Jiangsu Aidea Pharmaceutical Co., Ltd.
SHH: 688488.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jie Zhang
- Employees
- 476
- Headquarters
- Yangzhou, China
- IPO year
- 2020
- Market cap
- CN¥7.2B
- Website
- https://www.aidea.com.cn
Loading 688488…
Loading profile data…Frequently asked questions about 688488
What does Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS) do?
Jiangsu Aidea Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. It offers folium sennae granules, powdered bacillus tablets, clindamycin hydrochloride capsules, sodium bicarbonate tablets, nitrendipine tablets, metronidazole tablets, compound gentamycin sulfate and procaine hydrochloride sulfate granules, and cefrad...
Where does 688488.SS trade?
Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS) trades on the Shanghai Stock Exchange.
What sector is 688488.SS in?
Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Jiangsu Aidea Pharmaceutical Co., Ltd.?
Jie Zhang is the chief executive officer of Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS).
Where is Jiangsu Aidea Pharmaceutical Co., Ltd. headquartered?
Jiangsu Aidea Pharmaceutical Co., Ltd. is headquartered in China.
Does 688488.SS pay a dividend?
Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 688488.SS go public?
Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS) completed its initial public offering in 2020.